Previously, OPN was described as a protective factor against postmenopausal osteoporosis development, while OPG is a well‐known inhibitor of osteoclastogenesis that protects against age‐dependent osteoporosis development. The gene discussed is TNFRSF11B; the disease is osteoporosis.